It is known that genetic variation in AQP4 moderates the association between sleep and amyloid-β burden (Rainey-Smith et al., 2018), and, in AD, some specific AQP4 SNPs are related to steeper cognitive decline, whereas others relate to slower progression (Burfeind et al., 2017). The gene discussed is AQP4; the disease is Mental deterioration.